| Oct 1 |
ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
|
| Sep 30 |
Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses
|
| Sep 30 |
Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination
|
| Sep 16 |
Here's Why Investors Should Invest in Arcturus Stock Now
|
| Sep 13 |
Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma
|
| Sep 13 |
New Strong Buy Stocks for September 13th
|
| Sep 12 |
Top High Growth Tech Stocks to Watch in September 2024
|
| Sep 8 |
Arcturus Therapeutics Holdings Inc. (ARCT): Among the Worst ARK Stocks According to Short Sellers
|
| Sep 5 |
BioMarin Posts '27 Biz View, Outlines Growth Plans for Next 10 Years
|
| Sep 3 |
Arcturus Therapeutics Receives Clearance of an Investigational New Drug Application to U.S. Food and Drug Administration for ARCT-032, an Investigational Inhaled mRNA Therapeutic to Treat Cystic Fibrosis
|
